OTCMKTS:CTDH - CTD Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.68 0.00 (0.00 %) (As of 05/20/2019 12:23 PM ET)Previous Close$0.68Today's Range$0.68 - $0.6852-Week Range$0.28 - $1.18Volume12,920 shsAverage Volume5,171 shsMarket Capitalization$61.79 millionP/E RatioN/ADividend YieldN/ABeta-0.18 ProfileChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email CTD Holdings, Inc., a biotechnology company, develops cyclodextrin-based products for the treatment of diseases. Its lead drug candidate is Trappsol Cyclo, an orphan drug for the treatment of Niemann-Pick Type C disease. The company also sells cyclodextrins and related products to the pharmaceutical, nutritional, and other industries, primarily for use in diagnostics and specialty drugs. CTD Holdings, Inc. was founded in 1990 and is based in Gainesville, Florida. Receive CTDH News and Ratings via Email Sign-up to receive the latest news and ratings for CTDH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Industrial organic chemicals Sub-IndustryN/A SectorBasic Materials Current SymbolOTCMKTS:CTDH Previous Symbol CUSIPN/A CIK922247 Webwww.admabiologics.com Phone386-418-8060Debt Debt-to-Equity RatioN/A Current Ratio0.64 Quick Ratio1.22Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$1.01 million Price / Sales61.18 Cash FlowN/A Price / Cash FlowN/A Book Value($0.01) per share Price / Book-68.00Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-4,260,000.00 Net Margins-511.67% Return on Equity-1,509.36% Return on Assets-238.76%Miscellaneous Employees5 Outstanding Shares90,870,000Market Cap$61.79 million Next Earnings Date5/21/2019 (Estimated) OptionableNot Optionable CTD (OTCMKTS:CTDH) Frequently Asked Questions What is CTD's stock symbol? CTD trades on the OTCMKTS under the ticker symbol "CTDH." When is CTD's next earnings date? CTD is scheduled to release their next quarterly earnings announcement on Tuesday, May 21st 2019. View Earnings Estimates for CTD. Has CTD been receiving favorable news coverage? Headlines about CTDH stock have trended somewhat negative this week, InfoTrie Sentiment reports. The research group scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. CTD earned a coverage optimism score of -1.0 on InfoTrie's scale. They also gave news articles about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the stock's share price in the next several days. Who are some of CTD's key competitors? Some companies that are related to CTD include Sino United Worldwide Consolidated (SUIC), Solarwindow Technologies (WNDW), Dyadic International (DYAI), Pacific Ethanol (PEIX), Tantech (TANH), Aemetis (AMTX), Gevo (GEVO), Pledge Petroleum (PROP), OriginClear (OCLN), Mission Newenergy (MNELF), Methes Energies International (MEIL), Landstar (LDSR) and Wave Sync (WAYS). What other stocks do shareholders of CTD own? Based on aggregate information from My MarketBeat watchlists, some companies that other CTD investors own include Blackbird Energy (BBI), Abattis Bioceuticals (ATT), Globalstar (GSAT), Genocea Biosciences (GNCA), Second Sight Medical Products (EYES), EVINE Live (EVLV), Auris Medical (EARS), DURECT (DRRX), Capstone Turbine (CPST) and Asanko Gold (AKG). Who are CTD's key executives? CTD's management team includes the folowing people: Mr. N. Scott Fine, Chairman & CEO (Age 62)Dr. Jeffrey L. Tate, COO & Director (Age 61)Dr. Sharon H. Hrynkow, Chief Scientific Officer, SVP of Medical Affairs & Member of Scientific Advisory Board (Age 59)Mr. George L. Fails, Exec. VP and Operations Mang. (Age 74) How do I buy shares of CTD? Shares of CTDH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is CTD's stock price today? One share of CTDH stock can currently be purchased for approximately $0.68. How big of a company is CTD? CTD has a market capitalization of $61.79 million and generates $1.01 million in revenue each year. CTD employs 5 workers across the globe. What is CTD's official website? The official website for CTD is http://www.admabiologics.com. How can I contact CTD? CTD's mailing address is 6714 NW 16TH STREET SUITE B, GAINSVILLE FL, 32653. The biotechnology company can be reached via phone at 386-418-8060. MarketBeat Community Rating for CTD (OTCMKTS CTDH)Community Ranking: 2.0 out of 5 ( )Outperform Votes: 41 (Vote Outperform)Underperform Votes: 63 (Vote Underperform)Total Votes: 104MarketBeat's community ratings are surveys of what our community members think about CTD and other stocks. Vote "Outperform" if you believe CTDH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CTDH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/20/2019 by MarketBeat.com StaffFeatured Article: Oversold Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.